D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 71 Citations 14,629 374 World Ranking 3405 National Ranking 1204

Research.com Recognitions

Awards & Achievements

2018 - Fellow, National Academy of Inventors

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • Gene

His primary areas of study are Stereochemistry, Biochemistry, Topoisomerase, Topoisomerase-I Inhibitor and Camptothecin. His Stereochemistry research incorporates elements of Enzyme inhibitor, Enzyme, Biological activity, Structure–activity relationship and Chemical synthesis. His Biochemistry research integrates issues from Cancer cell, Cell culture and Tubulin.

His work carried out in the field of Topoisomerase brings together such families of science as Lactam, Cleavage, Isoquinoline and Cytotoxicity. His Topoisomerase-I Inhibitor study integrates concerns from other disciplines, such as Combinatorial chemistry, Base pair, Molecular model and Hydrogen bond. His Camptothecin study combines topics from a wide range of disciplines, such as DNA damage and Point mutation.

His most cited work include:

  • Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex (327 citations)
  • Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization. (304 citations)
  • Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents. (210 citations)

What are the main themes of his work throughout his whole career to date?

Mark Cushman mainly investigates Stereochemistry, Biochemistry, Topoisomerase, Cytotoxicity and Topoisomerase-I Inhibitor. The Stereochemistry study combines topics in areas such as Lumazine synthase, Enzyme, Riboflavin synthase, Structure–activity relationship and Chemical synthesis. His work in Biochemistry addresses issues such as Cancer cell, which are connected to fields such as Cancer research.

His Topoisomerase research integrates issues from Camptothecin, Cleavage, Lactam and Isoquinoline. The study incorporates disciplines such as Cell culture and Biological activity in addition to Cytotoxicity. His research in Topoisomerase-I Inhibitor intersects with topics in Combinatorial chemistry and Molecular model.

He most often published in these fields:

  • Stereochemistry (48.24%)
  • Biochemistry (22.72%)
  • Topoisomerase (20.14%)

What were the highlights of his more recent work (between 2012-2021)?

  • Topoisomerase (20.14%)
  • Stereochemistry (48.24%)
  • Pharmacology (7.03%)

In recent papers he was focusing on the following fields of study:

His main research concerns Topoisomerase, Stereochemistry, Pharmacology, Biochemistry and Cancer research. Mark Cushman has included themes like Camptothecin, Cancer cell and Cytotoxicity in his Topoisomerase study. Mark Cushman combines subjects such as Lactam and Cell culture with his study of Cytotoxicity.

His work carried out in the field of Stereochemistry brings together such families of science as Telithromycin, Biological activity, Staphylococcus aureus, Ketolide and Structure–activity relationship. His DNA, DNA damage and Coenzyme A study in the realm of Biochemistry connects with subjects such as Methylenedioxy. The concepts of his Topoisomerase-I Inhibitor study are interwoven with issues in Side chain and Mechanism of action.

Between 2012 and 2021, his most popular works were:

  • Discovery and Characterization of Potent Thiazoles versus Methicillin- and Vancomycin-Resistant Staphylococcus aureus (64 citations)
  • MAIT Recognition of a Stimulatory Bacterial Antigen Bound to MR1 (61 citations)
  • Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant Staphylococci (53 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Gene

The scientist’s investigation covers issues in Topoisomerase, Cytotoxicity, Biochemistry, Topoisomerase-I Inhibitor and Stereochemistry. Topoisomerase connects with themes related to Pharmacology in his study. His Cytotoxicity research is multidisciplinary, relying on both Lactam, Cell culture, DNA, DNA damage and Cancer cell.

His Biochemistry research incorporates themes from Triazine and Antibacterial activity. His research integrates issues of Camptothecin, IC50, Cancer research and Structure–activity relationship in his study of Topoisomerase-I Inhibitor. His Stereochemistry study incorporates themes from Biological activity, Dna cleavage, Cleavage, Tyrosyl-DNA phosphodiesterase and Side chain.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex

Bart L. Staker;Michael D. Feese;Mark Cushman;Yves Pommier.
Journal of Medicinal Chemistry (2005)

527 Citations

Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.

Mark Cushman;Dhanapalan Nagarathnam;D. Gopal;Asit K. Chakraborti.
Journal of Medicinal Chemistry (1991)

419 Citations

Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site.

Mark Cushman;Hu Ming He;John A. Katzenellenbogen;Chii M. Lin.
Journal of Medicinal Chemistry (1995)

304 Citations

Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents.

Mark Cushman;Dhanapalan Nagarathnam;D. Gopal;Hu Ming He.
Journal of Medicinal Chemistry (1992)

298 Citations

Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues.

Mark Cushman;Dhanapalan Nagarathnam;Debra L. Burg;Robert L. Geahlen.
Journal of Medicinal Chemistry (1991)

231 Citations

Selective Synthesis and Biological Evaluation of Sulfate-Conjugated Resveratrol Metabolites

Juma Hoshino;Eun Jung Park;Tamara P. Kondratyuk;Laura Marler.
Journal of Medicinal Chemistry (2010)

227 Citations

Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol.

Kshitij Thakkar;Robert L. Geahlen;Mark Cushman.
Journal of Medicinal Chemistry (1993)

219 Citations

Protein-Linked DNA Strand Breaks Induced by NSC 314622, a Novel Noncamptothecin Topoisomerase I Poison

Glenda Kohlhagen;Kenneth D. Paull;Mark Cushman;Pamela Nagafuji.
Molecular Pharmacology (1998)

204 Citations

Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitors.

Mark Cushman;Muthusamy Jayaraman;Jeffrey A. Vroman;Anna K. Fukunaga.
Journal of Medicinal Chemistry (2000)

197 Citations

A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex

Christophe Marchand;Smitha Antony;Kurt W. Kohn;Mark Cushman.
Molecular Cancer Therapeutics (2006)

178 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Mark Cushman

Yves Pommier

Yves Pommier

National Institutes of Health

Publications: 110

Adelbert Bacher

Adelbert Bacher

Technical University of Munich

Publications: 41

John M. Pezzuto

John M. Pezzuto

Western New England University

Publications: 39

Olga I. Lavrik

Olga I. Lavrik

Russian Academy of Sciences

Publications: 37

Ernest Hamel

Ernest Hamel

National Institutes of Health

Publications: 33

Markus Fischer

Markus Fischer

Universität Hamburg

Publications: 31

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 24

Alessandro Desideri

Alessandro Desideri

University of Rome Tor Vergata

Publications: 20

Barry V. L. Potter

Barry V. L. Potter

University of Oxford

Publications: 18

Christophe Marchand

Christophe Marchand

National Institutes of Health

Publications: 18

Edmond J. LaVoie

Edmond J. LaVoie

Rutgers, The State University of New Jersey

Publications: 17

Erik De Clercq

Erik De Clercq

Rega Institute for Medical Research

Publications: 16

Roshantha A. S. Chandraratna

Roshantha A. S. Chandraratna

Allergan (Ireland)

Publications: 16

Markus Fischer

Markus Fischer

University of Bern

Publications: 15

Jang Yang Chang

Jang Yang Chang

National Health Research Institutes

Publications: 14

James H. Doroshow

James H. Doroshow

National Institutes of Health

Publications: 14

Trending Scientists

Jorma Laaksonen

Jorma Laaksonen

Aalto University

Bhaskar DasGupta

Bhaskar DasGupta

University of Illinois at Chicago

Li Jian

Li Jian

Huazhong University of Science and Technology

Patrick Linder

Patrick Linder

University of Geneva

James J. Champoux

James J. Champoux

University of Washington

Richard H. Sibson

Richard H. Sibson

University of Otago

Bradford T. Stokes

Bradford T. Stokes

The Ohio State University

Walter Magerl

Walter Magerl

Heidelberg University

Andrej Kral

Andrej Kral

Hannover Medical School

Alan L. Rothman

Alan L. Rothman

University of Rhode Island

David N. McMurray

David N. McMurray

Texas A&M University

Dieter Vaitl

Dieter Vaitl

University of Giessen

Eric A. F. Simões

Eric A. F. Simões

University of Colorado Denver

Greta R. Bauer

Greta R. Bauer

University of Western Ontario

Michael Hill

Michael Hill

Newcastle University

Roberto Emparan

Roberto Emparan

University of Barcelona

Something went wrong. Please try again later.